Metis Innovative was formed in 2017 as an investment vehicle for promising early stage medical devices and technology in the neurosciences.

Founded by two prominent neurosurgeons in academic practice and a veteran of capital accrual for investment opportunities, the firm’s mission is to identify and invest in unique, well positioned companies focused on scientific breakthroughs. 

By coupling the experience of the physicians working with METIS Innovative in evaluating the likely clinical success of targeted technologies along with in-depth analysis of fiscal strategies and management structure of parent companies, we single out opportunities with potential for a high-yield investment return.